Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human fibrinogen in secondary hypofibrinogenemia
CTR20160039Phase 3Suspended
- Sponsor
- Sichuan Yuanda Shuyang Pharmaceutical
- Start
- Jan 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Fibrinogen human in hypofibrinogenemia, sponsored by Sichuan Yuanda Shuyang Pharmaceutical. Started Jan 2016; status: suspended.
02
Drugs
Fibrinogen human
03
Conditions
hypofibrinogenemia
Beyond the preview
Go deeper on CTR20160039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160039.